Pia Cosma, CRG researcher, participates in the dialogues on the boundaries of knowledge about “new approaches to the optogenetic neuronal control” at the #BISTConference19.
Pia Cosma has spoken on new approaches to the optogenetic neuronal control, together with Prof. Edward Boyden (Dept. of Biological Engineering, MIT), Prof. Valentina Emiliani (Institut de la Vision, CNRS, Paris), Prof. Ernest Giralt (Design, Synthesis and Structure of Peptides and Proteins Group, IRB Barcelona) and Prof. Michael Krieg (Neurophotonics And Mechanical Systems Biology Group, ICFO).
Optogenetics is a biological technique that involves the use of light to control cells in living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. As such, this technique can be used to study neural activity through light stimulation. It can furthermore help manage several central nervous system (CNS) diseases.
This technique could be applied together with other potential new therapeutic approaches for retinal dystrophies, which is of great importance in the area of Pia Cosma’s work: at her lab they inject “activated” stem cells that go to the retina of mice with pigmented retinosis and they fuse with damaged cells. This way cells are created initially with two nuclei that seem to regenerate the injured photoreceptors, thus restoring part of their vision.
A couple of years ago, a B-debate was organized on “Fighting Blindness. Challenges and future opportunities for visual restoration “, as session director and lecturer. This event took place at the CaixaForum in Barcelona. Organized jointly by B-Debate, a Biocat initiative and “la Caixa”, and the Barcelona Macula Foundation, with the collaboration of the CRG and the Leitat Foundation, the event proposed ideas to explore the potential of new therapeutic approaches for retinal dystrophies combining nanotechnology, regenerative medicine, stem cells, gene therapy, genomics, bioengineering, optogenetics and photonics.
Blindness is a major global health challenge because of the enormous impact it has on patients and their families, and their important socio-economic consequences. Besides the great emotional impact that this implies for patients and their families, also means the inability to pursue education, to find a quality job, an increased risk for falls and accidents, a limited autonomy and an impediment to have an active lifestyle and quality.









